FDA — authorised 30 August 1985
- Marketing authorisation holder: RANBAXY
- Status: approved
🇺🇸 Exelderm in United States
FDA authorised Exelderm on 30 August 1985
Marketing authorisations
FDA — authorised 30 August 1985
- Application: NDA018738
- Marketing authorisation holder: JOURNEY
- Local brand name: EXELDERM
- Indication: SOLUTION — TOPICAL
- Status: approved
FDA — authorised 28 February 1989
- Application: NDA018737
- Marketing authorisation holder: JOURNEY
- Local brand name: EXELDERM
- Indication: CREAM — TOPICAL
- Status: approved
Exelderm in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Exelderm approved in United States?
Yes. FDA authorised it on 30 August 1985; FDA authorised it on 30 August 1985; FDA authorised it on 28 February 1989.
Who is the marketing authorisation holder for Exelderm in United States?
RANBAXY holds the US marketing authorisation.